These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 4107718)

  • 1. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental active and passive immunization against rubella.
    Budai J; Tóth M; Melis L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
    [No Abstract]   [Full Text] [Related]  

  • 3. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 4. Arthritis associated with induced rubella infection.
    Ogra PL; Herd JK
    J Immunol; 1971 Sep; 107(3):810-3. PubMed ID: 4999096
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique.
    Al-Nakib W; Best JM; Banatvala JE
    Clin Exp Immunol; 1975 Nov; 22(2):293-301. PubMed ID: 813933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.
    Al-Nakib W; Best JM; Banatvala JE
    Lancet; 1975 Jan; 1(7900):182-5. PubMed ID: 47417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Passive immunization against rubella: studies on the effectiveness of rubella-immunoglobulin after intranasal infection with rubella vaccination virus].
    Neumann-Haefelin D; Neumann-Haefelin Ch; Petersen EE; Luthardt Th; Hass R
    Dtsch Med Wochenschr; 1975 Jan; 100(5):177-81. PubMed ID: 1112230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunity and anti-rubella vaccination].
    Delville JP; Tellini-Emma M
    Arch Belg Med Soc; 1970 May; 28(5):321-30. PubMed ID: 5494764
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality of the humoral immunity conferred by RA 27-3 rubella vaccine.
    Montagnon B; Boué A; Nicolas A; Tayot JL; Peyron L; Servajean B
    Biomedicine; 1973 Nov; 19(11):495-8. PubMed ID: 4599840
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response in school children to live rubella vaccine (Cendehill strain).
    Iwakata S; Elkerton LE; Rhodes AJ; Bull JA; Labzoffsky NA
    Can Med Assoc J; 1972 May; 106(9):980-2. PubMed ID: 4554732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of rubella immunity and resistance to infection.
    Davis WJ; Larson HE; Simsarian JP; Parkman PD; Meyer HM
    JAMA; 1971 Jan; 215(4):600-8. PubMed ID: 5107436
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunodeficiency with congenital rubella.
    Ribon A; Wasserman E
    Ann Allergy; 1973 Jan; 32(1):35-40. PubMed ID: 4128462
    [No Abstract]   [Full Text] [Related]  

  • 15. Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine.
    Saidi S; Naficy K
    Am J Dis Child; 1969 Aug; 118(2):209-12. PubMed ID: 5794816
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies with rubella vaccine (RA 27-3) using the subcutaneous and intranasal routes.
    Moffat MA; Gould JJ; Forbes FA; Freestone DS; Macdonald A
    Scott Med J; 1972 Apr; 17(4):140-2. PubMed ID: 4554067
    [No Abstract]   [Full Text] [Related]  

  • 17. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of rubella by demonstrating rubella-specific 19 S and 7 S antibodies (author's transl)].
    Dibbert HJ
    Zentralbl Bakteriol Orig A; 1976 Mar; 234(2):145-58. PubMed ID: 1274496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella vaccination. An evolving problem for obstetrics and gynecology.
    Monif GR
    Obstet Gynecol; 1972 Feb; 39(2):304-7. PubMed ID: 5057800
    [No Abstract]   [Full Text] [Related]  

  • 20. Rubella vaccination in adult females.
    Weibel RE; Stokes J; Buynak EB; Hilleman MR
    N Engl J Med; 1969 Mar; 280(13):682-5. PubMed ID: 5250184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.